Overview and Scope
Methenamine hippurate tablets are used as a medicine to prevent or control recurring urinary tract infections caused by specific bacteria. It is not used for any other active infections.
Sizing and Forecast
The methenamine hippurate tablets market size has grown strongly in recent years. It will grow from $8.97 billion in 2023 to $9.63 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to traditional uti treatment, antibiotic resistance concerns, clinical validation, physician prescription patterns, patient preference for non-antibiotic solutions.
The methenamine hippurate tablets market size is expected to see strong growth in the next few years. It will grow to $12.83 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing uti prevalence, rising antibiotic resistance concerns, advancements in uti management, healthcare focus on preventive therapies,clinical trials and research. Major trends in the forecast period include increased uti incidence, rising antibiotic resistance, preference for non-antibiotic treatments, focus on preventive healthcare, research and development.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report
Segmentation & Regional Insights
The methenamine hippurate tablets market covered in this report is segmented –
1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs
4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users
North America was the largest region in the methenamine hippurate tablets market in 2023. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp
Major Driver Impacting Market Growth
An increasing geriatric population is expected to boost the growth of the methenamine hippurate tablets market going forward. Geriatric population refers to the population of older people of 60 years and above. Geriatric patients are more vulnerable to urinary tract infections due to a variety of factors such as decreased urine flow, an enlarged prostate, or kidney stones, thus methenamine hippurate tablets are required to treat these conditions. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, one in six individuals on the planet will be 60 or older by 2030. In 2021, there were 1.4 billion people over the age of 60. The number of persons who are 60 years or older globally will double by 2050 (2.1 billion). The number of people who are 80 years or older is projected to treble, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the methenamine hippurate tablets market.
Key Industry Players
Major companies operating in the methenamine hippurate tablets market are making collaborations to increase their profitability in the market. Strategic collaboration is a purposeful partnership between entities to achieve mutual goals through coordinated efforts, leveraging each other’s strengths and resources. For instance, in May 2023, EQL Pharma AB, a Sweden-based pharmaceutical company that provides methenamine hippurate tablets, collaborated with Dr. Pfleger Arzneimittel GmbH. Through this calloboration, EQL Pharma AB aims to launch Methenamine Hippurate with an EQL-registered brand within the next two years with standard license fees, regulatory and reimbursement milestones, and a volume-dependent supply price with regulatory approval. Dr. Pfleger Arzneimittel GmbH is a Germany based pharmaceutical company.
The methenamine hippurate tablets market report table of contents includes:
1. Executive Summary
2. Methenamine Hippurate Tablets Market Characteristics
3. Methenamine Hippurate Tablets Market Trends And Strategies
4. Methenamine Hippurate Tablets Market – Macro Economic Scenario
5. Global Methenamine Hippurate Tablets Market Size and Growth
….
31. Global Methenamine Hippurate Tablets Market Competitive Benchmarking
32. Global Methenamine Hippurate Tablets Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Methenamine Hippurate Tablets Market
34. Methenamine Hippurate Tablets Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
